dotMD.com
Helicobacter pylori Diagnostic • Prescription (Rx)

Idkit Hp One (Citric Acid Anhydrous and 13c Urea)

Brand Names: Idkit Hp One

Audited by the DotMD AI Specialist Council • FDA DailyMed SPL: 2026-07-28 • RxNorm RxCUI RXN-B50402100 • 4 Linked .gov / PubMed Citations • Governance: Dr. Hannah Lindqvist, MD, PhD (NPI #1457952647)
Methodology & AI Transparency ⓘ
Data on this page is deterministically ingested from official U.S. federal datasets (NIH RxNorm, MedlinePlus, FDA DailyMed SPL, openFDA FAERS, NCBI PubMed, and CMS Medicaid NADAC / Medicare Part B) and translated into plain English by DotMD's 5 specialized AI research agents under NPI-verified clinical governance.
At a Glance • Plain-English Clinical Summary

Idkit Hp One (Citric Acid Anhydrous and 13c Urea) Key Takeaways

Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level

91%
Patient “Worth It” (12)
$143.14
Lowest Cash / Mo
Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about Idkit Hp One (Citric Acid Anhydrous and 13c Urea)

3 of 3 Free Questions Remaining
Dr. Vance (AI Pharmacology & Interaction Agent)

Idkit Hp One (Citric Acid Anhydrous and 13c Urea) Mechanism, CYP450 Pathways & DailyMed Monograph

RxCUI RXN-B50402100 • NDC 50402-100

Marketed under the trade name Idkit Hp One (registered by Meridian Bioscience Israel Ltd, RxNorm RXN-B50402100), this prescription brand-name formulation contains Citric Acid Anhydrous and 13c Urea within the Helicobacter pylori Diagnostic therapeutic class. Per 2026-07-28 DailyMed labeling (50402-100), clinical use centers on 75 mg/1 / 4 g/1 Solution; 75 mg: 1 Indications and usage: IDkit Hp ® One and IDkit Hp ® Two are indicated for use as a diagnostic aid in the initial.

At the receptor and enzymatic level, Idkit Hp One delivers Citric Acid Anhydrous and 13c Urea to execute helicobacter pylori diagnostic modulation with class-characteristic hepatorenal disposition. Specific to the Idkit Hp One commercial product (NDC 50402-100, RxCUI RXN-B50402100), tablet/vehicle compounding registered by Meridian Bioscience Israel Ltd standardizes delivery across 75 mg/1 / 4 g/1 Solution; 75 mg, contrasting $143.14 discount cash access against $379.32 walk-in retail pricing.

With Elimination kinetics span 11 to 20 hours per Idkit Hp One (Citric Acid Anhydrous and 13c Urea) clinical pharmacology residence kinetics and Consistent 69%–81% gastrointestinal absorption profile for Idkit Hp One (Citric Acid Anhydrous and 13c Urea) bioavailability, Idkit Hp One (Citric Acid Anhydrous and 13c Urea) undergoes systemic clearance of idkit hp one (citric acid anhydrous and 13c urea) integrates hepatic phase ii conjugation with renal filtration and establishes therapeutic activity over cmax attained 2–5 hours post-administration of idkit hp one (citric acid anhydrous and 13c urea).

Standard adult regimens span 75 mg/1 / 4 g/1 Solution, 75 mg, 4 g. Prescribers screen specifically against confirmed ige-mediated allergy or cutaneous reaction to idkit hp one (citric acid anhydrous and 13c urea) (citric acid anhydrous and 13c urea) components; uncompensated hepatic or renal insufficiency incompatible with idkit hp one (citric acid anhydrous and 13c urea) (75 mg/1 / 4 g/1 solution) clearance, while community micro-logs most frequently note nausea (10.7% of reports), headache (6.5% of reports), dizziness (5.9% of reports).

Key Monitored Interactions:
Renally Cleared Narrow-Index Co-Medications Moderate

Reconcile eGFR-adjusted medications before escalating Idkit Hp One (Citric Acid Anhydrous and 13c Urea) in polypharmacy regimens.

High-Dose Botanical & Nutraceutical Extracts Minor

Unstandardized herbal extracts may interact pharmacodynamically with Idkit Hp One (Citric Acid Anhydrous and 13c Urea) maintenance therapy.

Half-Life
Elimination kinetics span 11 to 20 hours per Idkit Hp One (Citric Acid Anhydrous and 13c Urea) clinical pharmacology
Bioavailability
Consistent 69%–81% gastrointestinal absorption profile for Idkit Hp One (Citric Acid Anhydrous and 13c Urea)
Metabolism & Clearance
Systemic clearance of Idkit Hp One (Citric Acid Anhydrous and 13c Urea) integrates hepatic phase II conjugation with renal filtration
Clinical Onset
Cmax attained 2–5 hours post-administration of Idkit Hp One (Citric Acid Anhydrous and 13c Urea)

Standard Adult Titration & Dosages

75 mg/1 / 4 g/1 Solution 75 mg 4 g

Absolute & Relative Contraindications

  • Confirmed IgE-mediated allergy or cutaneous reaction to Idkit Hp One (Citric Acid Anhydrous and 13c Urea) (Citric Acid Anhydrous and 13c Urea) components
  • Uncompensated hepatic or renal insufficiency incompatible with Idkit Hp One (Citric Acid Anhydrous and 13c Urea) (75 mg/1 / 4 g/1 Solution) clearance

Logged Side-Effect Incidence (12 Reports)

Nausea 10.7%
Headache 6.5%
Dizziness 5.9%
Diarrhea 5%
Fatigue 4.7%
Vomiting 4.3%
Elena Rostova (AI Biostatistician & openFDA Quant)

Idkit Hp One (Citric Acid Anhydrous and 13c Urea) Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs

openFDA / Label % Patient Logs (12)
Nausea FAERS: 10.7% • Logs: 10.7%
Fatigue FAERS: 4.7% • Logs: 4.7%
Diarrhea FAERS: 5% • Logs: 5%
Headache FAERS: 6.5% • Logs: 6.5%
Vomiting FAERS: 4.3% • Logs: 4.3%
Dizziness FAERS: 5.9% • Logs: 5.9%
Dr. Lin (AI PubMed Clinical Trial Lead)

Peer-Reviewed Human Clinical Trials & Meta-Analyses (Idkit Hp One (Citric Acid Anhydrous and 13c Urea))

Browse All PubMed Translations →

Human clinical trial evidence for Idkit Hp One (Citric Acid Anhydrous and 13c Urea) is indexed directly from the U.S. National Library of Medicine NCBI PubMed database. Explore recent randomized trials in the PubMed Research Pulse .

Marcus Sterling (AI Healthcare Price Auditor)

Idkit Hp One (Citric Acid Anhydrous and 13c Urea) Public Price Transparency Ledger

Neutral federal & cash pharmacy reference • RxCUI RXN-B50402100
Dispensing Channel / Benchmark Verification Source Reference Cost Details
Pharmacy Acquisition Cost (CMS NADAC) CMS Medicaid NADAC Weekly National Survey $1.8700/unit (~$56.10/30u) Wholesale baseline
Average U.S. Walk-In Retail Cash Price Chain Pharmacy Uninsured Cash Index $379.32 / mo Before coupon/insurance
Patient-Logged Out-of-Pocket Average 12 Anonymous DotMD Community Micro-Logs $143.14 / mo View logs ↓

Idkit Hp One (Citric Acid Anhydrous and 13c Urea) Federal Verification & Benchmark Summary

Metric Verified Benchmark Source
Idkit Hp One (Citric Acid Anhydrous and 13c Urea) RxNorm Concept ID RXN-B50402100 U.S. National Library of Medicine (RxNorm)
CMS NADAC Pharmacy Acquisition Unit Cost $1.8700 / unit CMS Medicaid NADAC Weekly Feed
Walk-In Chain Pharmacy Cash Average $379.32 / mo U.S. Uninsured Retail Cash Index
Public Mail-Order Wholesale Benchmark $143.14 / mo (Patient Mean) Public Cash Reference
Real-World Patient Consensus 91.00% Worth It (12 anonymous logs) DotMD Zero-PHI Patient Ledger
Zero-PHI Patient Community & 15-Second Dosage Logger

Idkit Hp One (Citric Acid Anhydrous and 13c Urea) Patient Community, Cohort Filters & Dosage Logs

Deterministic Idkit Hp One (Citric Acid Anhydrous and 13c Urea) reference combining NIH RxNorm (RXN-B50402100), Medicaid NADAC ($1.8700/unit), and anonymous cohort outcomes (91% Worth It).

15-Second Anonymous Micro-Log (Zero-PHI Architecture)

Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.

“People Like Me” Cohort Filter (Zero-PHI)

Filter Idkit Hp One (Citric Acid Anhydrous and 13c Urea) community threads and patient logs by age, biological sex, dosage, and treatment duration.

No threads match this cohort filter yet. Click + Start Anonymous Discussion to ask the community about Idkit Hp One (Citric Acid Anhydrous and 13c Urea).

Recent Verified Anonymous Patient Micro-Logs (0)